PHARMACOPEIA INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$4.0M

408 transactions

Summary

PHARMACOPEIA INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $1.7MSales: $807K26 insiders

Date	Insider	Type	Value
2008-12-23	Belder Rene(SVP, Clinical & Regulatory)	D	$20K
2008-12-23	Belder Rene(SVP, Clinical & Regulatory)	D	$15K
2008-12-23	Costalas Stephen C(EVP, General Counsel)	D	$14K
2008-12-23	Costalas Stephen C(EVP, General Counsel)	D	$11K
2008-12-23	Costalas Stephen C(EVP, General Counsel)	D	$8K
2008-12-23	Costalas Stephen C(EVP, General Counsel)	D	$8K
2008-12-23	POSNER BRIAN M(EVP, CFO)	D	$5K
2008-12-23	Costalas Stephen C(EVP, General Counsel)	D	$4K
2008-12-23	Belder Rene(SVP, Clinical & Regulatory)	D	$4K
2008-12-23	Costalas Stephen C(EVP, General Counsel)	D	$3K
2008-12-23	Belder Rene(SVP, Clinical & Regulatory)	D	$3K
2008-12-23	Costalas Stephen C(EVP, General Counsel)	D	$3K
2008-12-23	Costalas Stephen C(EVP, General Counsel)	D	$2K
2008-12-23	POSNER BRIAN M(EVP, CFO)	D	$2K
2008-12-23	Belder Rene(SVP, Clinical & Regulatory)	D	$833.4
2008-12-23	BARTLETT PAUL A	D	—
2008-12-23	Belder Rene(SVP, Clinical & Regulatory)	F	—
2008-12-23	Belder Rene(SVP, Clinical & Regulatory)	D	—
2008-12-23	Costalas Stephen C(EVP, General Counsel)	D	—
2008-12-23	MOLLICA JOSEPH A(Chairman, Interm-President/CEO)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

PHARMACOPEIA INC — Contributions, Lobbying & Contracts | Poliscope